Lobbying

The Conafay Group's latest lobbying report covers Q3 2025, at under $5,000. Its first report covers Q1 2023; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.

The Conafay Group

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2023
The first quarter a report named it

Lobbying by quarter

The Conafay Group lobbying by quarter
The Conafay Group lobbying by quarter
QuarterAmountReports
Q1 2023$10K1
Q2 2023$30K1
Q3 2023$30K1
Q4 2023$30K1
Q1 2024$20K1
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$01
Q3 2025$01
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$40K · 5 reports
  • Medical research and clinical labs$40K · 5 reports
  • Science and technology$40K · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES5 reports

Firms it paid

Firm
Bradley Arant Boult Cummings$120K11 quarters

Former officials lobbying for it

Former position
DAVID STEWARTLegislative Correspondent, Senator Jeff SessionsQ1 2024
MARTHA ROBYFormer Member of U.S. House of RepresentativesQ1 2024

Lobbying reports

Filed by
25/10/20for Q3 2025Bradley Arant Boult CummingsUnder $5,000
25/07/21for Q2 2025Bradley Arant Boult CummingsUnder $5,000
25/04/21for Q1 2025Bradley Arant Boult CummingsUnder $5,000
25/01/21for Q4 2024Bradley Arant Boult CummingsUnder $5,000
24/10/21for Q3 2024Bradley Arant Boult CummingsUnder $5,000
24/07/22for Q2 2024Bradley Arant Boult CummingsUnder $5,000
24/04/22for Q1 2024Bradley Arant Boult Cummings$20K
24/01/22for Q4 2023Bradley Arant Boult Cummings$30K
23/10/20for Q3 2023Bradley Arant Boult Cummings$30K
23/07/20for Q2 2023Bradley Arant Boult Cummings$30K
23/04/20for Q1 2023Bradley Arant Boult Cummings$10K
23/04/12for Q1 2023Bradley Arant Boult CummingsUnder $5,000